Business
Arrowhead Pharmaceuticals to Webcast Fiscal 2026 First Quarter Results
PASADENA, Calif., January 20, 2026--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it will host a webcast and conference call on February 5, 2026, at 4:30 p.m. ET to discuss its financial results for the fiscal 2026 first quarter ended December 31, 2026.
About this update from Arrowhead Pharmaceuticals, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1609,"height":335,"url":"https://media.zenfs.com/en/business-wire.com/a65042d8c8929e1b5632c98994e8a6a9"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/7ICNtfD_8cbjdA_WFfXbiQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTIwMDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/a65042d8c8929e1b5632c98994e8a6a9","width":960,"height":200},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/wOzzKnjt79IcpczUxQztaw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD01MDA7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/a65042d8c8929e1b5632c98994e8a6a9","width":1200,"height":250}},"lazy":false},{"type":"text","content":"PASADENA, Calif., January 20, 2026--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it will host a webcast and conference call on February 5, 2026, at 4:30 p.m. ET to discuss its financial results for the fiscal 2026 first quarter ended December 31, 2026.","length":292,"tagName":"p"},{"type":"text","content":"Webcast and Conference Call Details","length":35,"tagName":"p"},{"type":"text","content":"Investors may access a live audio webcast on the Events and Presentations page under the Investors section of the Arrowhead website. A replay of the webcast will be available approximately two hours after the conclusion of the call.","length":232,"tagName":"p"},{"type":"text","content":"For analysts that wish to participate in the conference call, please register at https://register-conf.media-server.com/register/BIf75928b390fb452f963ab43a18d60220. Once registered, you will receive the dial-in number and a personalized PIN code that will be required to access the call.","length":287,"tagName":"p"},{"type":"text","content":"About Arrowhead Pharmaceuticals","length":31,"tagName":"p"},{"type":"text","content":"Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep, and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a spec...